A breakthrough in the quest to find a blood test for Alzheimer's will help doctors and patients "manage the disease", one of the researchers has said.
Professor Howard Federoff explained:
Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder.
The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention.
Biomarkers such as ours that define this asymptomatic period are critical for successful development and application of these therapeutics.
We consider our results a major step toward the commercialisation of a preclinical disease biomarker test.
More top news
China's President is the country's most powerful ruler in decades, but who is Xi Jingping and how did he become so powerful?
David Clarke has been charged with false imprisonment and possession of a sawn-off shotgun and a samurai sword, along with other charges.
It remains in Britain's hands whether it ends up with a good deal, no deal or no Brexit at all, according to the European Council president.